Skip to content

Ascentage Pharma

US · AAPG #3045 by market cap Listed 2025
11.97 -0.47 -3.78%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2025/12/4
  • Rating change
    Oppenheimer Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/8/21
  • Rating change
    Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $51
    Market Newswire · 2026/3/27
  • Rating change
    B. Riley Securities Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/9/2
  • Rating change
    Analysts Offer Insights on NA Companies: Ascentage Pharma Group International Unsponsored ADR (AAPG), Fatpipe, Inc. (FATN) and Aptera Motors Corp. Class B (SEV)
    TipRanks · 2026/8/21
  • Rating change
    Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $22.34
    Market Newswire · 2026/4/24
  • Citi Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/10/15
  • Rating change
    J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $46
    Market Newswire · 2026/4/16
  • Company notice
    HyTerra Ltd: AAPG Mid-Continent Sectional Conference Presentation
    ASX · 2025/10/8
  • Rating change
    Lucid Capital Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $50
    Market Newswire · 2025/12/15
  • Citi Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $46
    Market Newswire · 2026/10/15
  • Rating change
    Deutsche Bank Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $40
    Market Newswire · 2026/4/24
  • Rating change
    Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating
    Market Newswire · 2026/8/21
  • Rating change
    BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48
    Market Newswire · 2026/3/12
  • Rating change
    B. Riley Securities Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
    Market Newswire · 2026/6/10
  • Rating change
    Piper Sandler Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/6/1
  • J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $33
    Market Newswire · 2026/10/9
  • Citizens JMP Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $35
    Market Newswire · 2026/10/14
  • Rating change
    Oppenheimer Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
    Market Newswire · 2026/6/15
  • BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/11/6
  • Rating change
    BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/8/21
  • Rating change
    BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $50
    Market Newswire · 2025/11/10
  • Rating change
    J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating
    Market Newswire · 2025/8/22
  • Rating change
    Piper Sandler Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48
    Market Newswire · 2025/11/5
  • Rating change
    J.P. Morgan Initiates Ascentage Pharma(AAPG.US) With Buy Rating
    Market Newswire · 2025/7/28

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

Ascentage Pharma discussion 0 comments

Add a comment